Primary care physicians and internists who have tried "temping" have found something to their liking: fewer hassles, decent money, and enough perks to make it economically feasible. In fact, 7 of 10 physicians surveyed by a major health care recruiting company say they are more satisfied in their locum tenens assignments than they were in their previous permanent positions.

Many of the physicians in temporary assignments surveyed by Salt Lake City-based CompHealth are young doctors, still relatively early in their careers. The company says average compensation for locum tenens physicians is comparable to that of family practitioners and internists in their first years of practice — $100,000 for 48 weeks — while such perks as benefits, furnished housing and transportation, and not having to pay malpractice premiums make it an even game.

Compensation was not specifically factored into CompHealth's satisfaction survey, but it is an important part of physicians' overall satisfaction with their work. The benefits mentioned above and a lack of having to worry about compensation issues (described below) don't hurt. Their value, both financially and from a peace-of-mind standpoint, can be incalculable.

What CompHealth did calculate was how the reduced hassle when temping influences overall job satisfaction. The survey found that, of locum tenens physicians:

  • 81 percent do not deal with medical malpractice issues
  • 76 percent do not deal with Medicare and Medicaid payment issues
  • 42 percent do not deal with managed care issues

Physicians also like the freedom — some, for instance, work near their homes in cold-weather states during the summer, then take assignments in warm-weather locations during the winter. The travel, living arrangements, and means of transportation in the warm-weather locales are financed by the staffing company while the physician is on assignment.

Only 1 in 10 were less satisfied with temporary work than permanent assignments.

Average compensation, temp vs. full time



Compared to your last permanent position, how satisfied are you with locum tenens work?

Figures are rounded and "not sure" responses are not shown. Therefore, figures do not add to 100 percent.


Managed Care’s Top Ten Articles of 2016

There’s a lot more going on in health care than mergers (Aetna-Humana, Anthem-Cigna) creating huge players. Hundreds of insurers operate in 50 different states. Self-insured employers, ACA public exchanges, Medicare Advantage, and Medicaid managed care plans crowd an increasingly complex market.

Major health care players are determined to make health information exchanges (HIEs) work. The push toward value-based payment alone almost guarantees that HIEs will be tweaked, poked, prodded, and overhauled until they deliver on their promise. The goal: straight talk from and among tech systems.

They bring a different mindset. They’re willing to work in teams and focus on the sort of evidence-based medicine that can guide health care’s transformation into a system based on value. One question: How well will this new generation of data-driven MDs deal with patients?

The surge of new MS treatments have been for the relapsing-remitting form of the disease. There’s hope for sufferers of a different form of MS. By homing in on CD20-positive B cells, ocrelizumab is able to knock them out and other aberrant B cells circulating in the bloodstream.

A flood of tests have insurers ramping up prior authorization and utilization review. Information overload is a problem. As doctors struggle to keep up, health plans need to get ahead of the development of the technology in order to successfully manage genetic testing appropriately.

Having the data is one thing. Knowing how to use it is another. Applying its computational power to the data, a company called RowdMap puts providers into high-, medium-, and low-value buckets compared with peers in their markets, using specific benchmarks to show why outliers differ from the norm.
Competition among manufacturers, industry consolidation, and capitalization on me-too drugs are cranking up generic and branded drug prices. This increase has compelled PBMs, health plan sponsors, and retail pharmacies to find novel ways to turn a profit, often at the expense of the consumer.
The development of recombinant DNA and other technologies has added a new dimension to care. These medications have revolutionized the treatment of rheumatoid arthritis and many of the other 80 or so autoimmune diseases. But they can be budget busters and have a tricky side effect profile.

Shelley Slade
Vogel, Slade & Goldstein

Hub programs have emerged as a profitable new line of business in the sales and distribution side of the pharmaceutical industry that has got more than its fair share of wheeling and dealing. But they spell trouble if they spark collusion, threaten patients, or waste federal dollars.

More companies are self-insuring—and it’s not just large employers that are striking out on their own. The percentage of employers who fully self-insure increased by 44% in 1999 to 63% in 2015. Self-insurance may give employers more control over benefit packages, and stop-loss protects them against uncapped liability.